封面
市場調查報告書
商品編碼
1929654

部分可吸收疝氣修補網片市場:按產品類型、手術入路、固定方法、吸收率、應用、最終用戶分類的全球預測(2026-2032年)

Partially Absorbable Hernia Repair Mesh Market by Product Type, Surgery Approach, Fixation Method, Absorption Rate, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年部分可吸收疝氣修補網片市場價值為 8.7637 億美元,預計到 2026 年將成長至 9.4009 億美元,年複合成長率為 6.72%,到 2032 年將達到 13.8221 億美元。

關鍵市場統計數據
基準年 2025 8.7637億美元
預計年份:2026年 9.4009億美元
預測年份 2032 13.8221億美元
複合年成長率 (%) 6.72%

部分可吸收疝氣修補網片代表了生物材料科學、不斷發展的外科技術以及致力於改善患者預後和提高醫療服務成本效益的醫療保健系統之間的關鍵交匯點。這類網片結合了永久性聚合物和可吸收聚合物的特性,在提供初始機械支撐的同時,隨著可吸收成分的分解,負荷逐漸轉移到活體組織。由於這類網片能夠減少慢性異物反應、最大限度地降低長期併發症,並在關鍵的癒合期內保持持久的修補強度,因此越來越受到醫療專業人員的青睞。

近期產品改善主要集中在精確控制吸收率、混合聚合物以及新型固定技術等方面,旨在最佳化操作性並縮短手術時間。同時,日益嚴格的監管審查和證據要求促使製造商加強對強大的臨床前和臨床項目的投資。醫療系統和採購者不再只關注器械的初始價格,而是更注重臨床療效、併發症情況以及對整體醫療成本的影響。因此,從產品開發到採購的各個環節的相關人員正在重新評估部分可吸收解決方案在不斷發展的疝氣治療路徑中的定位。

本文為重點分析技術變革、貿易和政策逆風、細分市場細微差別以及區域特定趨勢奠定了基礎,旨在揭示臨床領導者、產品團隊和商業負責人可以利用的可操作見解,以改進市場定位、優先考慮投資並加速在競爭激烈且監管嚴格的外科器械市場中的應用。

生物材料、外科手術方法和實證醫學領域的關鍵轉折點正在重新定義產品選擇、採購決策和競爭定位。

部分可吸收疝氣修補網片的市場格局正經歷變革,這主要得益於材料創新、微創手術的普及以及對實際臨床療效的日益重視。聚合物科學的進步使得將聚丙烯或聚酯主鏈與Poliglecaprone和聚乙醇酸等可吸收聚合物相結合成為可能,從而製造出兼具初始拉伸強度和可控吸收動力學的植入。這些混合結構迫使外科醫師重新評估其器材選擇,必須將組織整合和長期異物效應納入考量。

累積關稅變化如何重塑各行業的採購重點、供應鏈韌性、監管合規負擔和商業性價值提案

2025年美國關稅調整為部分可吸收疝氣修補網片的製造商、經銷商和採購商帶來了新的考量。關稅調整提升了上游採購決策的重要性,迫使相關人員重新評估其供應商佈局。對於依賴進口原料、塗層材料或成品網片的公司而言,最直接的影響是籌資策略的重新調整,即供應鏈多元化,並盡可能更專注於近岸外包。

綜合細分說明,將產品配方、臨床應用、手術方法、固定策略、最終用戶、分銷模式和吸收因素連結起來

了解部分可吸收疝氣修補網片的細分市場對於將臨床需求與產品設計和商業策略相匹配至關重要。在考慮產品類型時,可分為聚乙烯/Poliglecaprone/聚乙醇酸組合,以及聚丙烯/Poliglecaprone和聚丙烯/聚乙醇酸組合。每種混合物都具有不同的操作特性、組織整合性和吸收特性,以滿足不同的手術偏好和組織環境。

區域臨床重點、法規結構和採購行為將如何導致美洲、歐洲、中東和非洲以及亞太地區採取不同的採納路徑和戰略應對措施

區域趨勢正在以不同的方式塑造美洲、歐洲、中東和非洲以及亞太地區的競爭優勢、臨床應用模式和監管應對措施。在美洲,眾多領先的外科中心高度集中,且醫療報銷環境強調長期治療效果,這推動了對擁有強力臨床證據和外科醫生培訓項目的醫療設備的需求。該地區的採購週期側重於合約執行、供應可靠性以及對患者報告結果的顯著影響。

供應商在材料創新、臨床證據投資、外科醫生培訓、法規遵循和服務商品搭售的策略如何塑造競爭優勢

主要企業之間的競爭特點是:持續投資於材料科學、不斷拓展臨床證據項目,以及建立策略聯盟以加強分銷和臨床培訓。每家公司都透過以下方式實現差異化:採用可精確調節吸收率和機械性能的聚合物混合物;採用專有的生產流程,確保產品的均一性和無菌性;以及採用表面處理技術,促進組織長入並減少發炎反應。

為市場領導提供切實可行的策略,以推動產品應用、強化價值鏈,並將臨床證據轉化為對醫療保健採購者俱有吸引力的價值提案。

致力於轉型為市場領導者的行業領導者應將產品開發、監管策略和商業性執行與以下幾個高影響力優先事項相協調。首先,投資於模組化產品平台,該平台能夠對吸收率和機械性能進行迭代調整,從而無需徹底重新設計即可在多種適應症中累積臨床證據。這種方法可以加快產品在相鄰適應症中的臨床應用速度,並透過針對每種組織環境最佳化吸收動力學,實現顯著差異化。

採用嚴謹的混合調查方法,結合臨床醫生訪談、法規和文獻綜述以及同行檢驗,以得出可操作的、基於證據的研究結果。

本分析的調查方法融合了定性和定量技術,以確保研究的深度、多方驗證和實際應用價值。主要定性資料透過對微創和開放式疝氣修補術的外科醫生、醫院和門診手術中心的採購人員以及醫療設備核准途徑的監管和報銷專家進行結構化訪談收集。這些訪談提供了關於器材操作偏好、固定技術選擇和臨床證據優先順序的第一手觀點。

將產品創新、證據要求和營運韌性相結合,以此為基礎,實現疝氣修補術的持續推廣應用並改善患者預後。

部分可吸收疝氣修補網片代表了材料科學、外科技術改進和以結果為導向的醫療採購的整合。在產品開發、臨床應用和商業化的各個階段,最成功的企業將是那些將高品質的臨床證據與強大的供應鏈以及客製化的商業模式相結合的企業,這些模式能夠滿足醫院、門診手術中心和專科診所的獨特需求。對聚合物最佳化、固定技術創新和外科醫生參與專案的策略投資將繼續推動差異化發展。

目錄

第1章:序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

8. 依產品類型分類的部分可吸收疝氣修補網片市場

  • 聚酯纖維和Poliglecaprone
  • 聚酯和聚乙醇酸
  • 聚丙烯和Poliglecaprone
  • 聚丙烯和聚乙醇酸

9. 依手術方式分類的部分可吸收疝氣修補網片市場

  • 腹腔鏡
    • 完全腹膜外
    • 經腹膜前入路
  • 開放性手術
    • 列支敦斯登法律
    • 即插即用
  • 機器人輔助

10. 以固定方式分類的部分可吸收疝氣修補網片市場

  • 黏合劑
  • 自修復
  • 縫合

11. 依吸收率分類的部分可吸收疝氣修補網片市場

  • 中速
  • 迅速的
  • 慢的

12. 依應用分類的部分可吸收疝氣修補網市場

  • 大腿
  • 鼠蹊部
  • 臍疝氣
  • 腹壁
    • 切口
    • 原發性腹壁疝

13. 依最終用戶分類的部分可吸收疝氣修補網市場

  • 門診手術中心
  • 醫院
  • 專科診所

14. 各地區部分可吸收疝氣修補網片市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

15. 部分可吸收疝氣修補網片市場(依類別分類)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國部分可吸收疝氣修補網片市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國部分可吸收疝氣修補網片市場

18. 中國部分可吸收疝氣修補網片市場

第19章 競爭情勢

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • AbbVie Inc.
  • Aran Biomedical by Integer Holdings Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Coloplast A/S
  • CooperSurgical, Inc.
  • Cousin Surgery
  • Deep Blue Medical Advances, Inc.
  • Dolphin Sutures
  • Getinge AB
  • HERNIAMESH Srl
  • Hwainmedi Co., Ltd.
  • Insightra Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KATSAN Katgut Sanayi ve Tic. AS
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Momentis Surgical Ltd.
  • Novus Scientific AB
  • Olympus Corporation
  • Secant Group, LLC
  • Surgimatix, Inc.
  • TELA Bio, Inc.
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0A3806951871

The Partially Absorbable Hernia Repair Mesh Market was valued at USD 876.37 million in 2025 and is projected to grow to USD 940.09 million in 2026, with a CAGR of 6.72%, reaching USD 1,382.21 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 876.37 million
Estimated Year [2026] USD 940.09 million
Forecast Year [2032] USD 1,382.21 million
CAGR (%) 6.72%

Partially absorbable hernia repair mesh occupies an important intersection between biomaterials science, surgical technique evolution, and health systems seeking improved patient outcomes alongside cost-efficient care delivery. This category of mesh blends permanent and resorbable polymer characteristics to provide early mechanical support while enabling gradual load transfer to native tissue as the absorbable component degrades. Clinicians are increasingly attracted to these designs for the potential to reduce chronic foreign-body response, minimize long-term complications, and maintain durable repair strength during the critical healing window.

Recent device iterations emphasize finer control over absorption rates, hybrid polymer blends, and novel fixation approaches to optimize handling and reduce operative time. At the same time, regulatory scrutiny and evidence expectations have elevated, prompting manufacturers to invest in robust preclinical and clinical programs. Health systems and purchasers are responding by scrutinizing clinical outcomes, complication profiles, and total cost of care implications rather than focusing solely on upfront device price. As a result, stakeholders from product development to procurement are re-evaluating how partially absorbable solutions fit into evolving hernia care pathways.

This introduction sets the stage for a focused analysis that traces technological shifts, trade and policy headwinds, segmentation nuances, and region-specific dynamics. The goal is to surface actionable insights that clinical leaders, product teams, and commercial strategists can use to refine positioning, prioritize investments, and accelerate adoption in a competitive and tightly regulated surgical device landscape.

Critical inflection points in biomaterials, surgical approaches, and evidence generation that are redefining product selection, procurement decisions, and competitive positioning

The landscape for partially absorbable hernia repair mesh is undergoing transformative shifts driven by materials innovation, minimally invasive surgical expansion, and a heightened emphasis on real-world clinical outcomes. Advances in polymer science have enabled formulations that combine polypropylene or polyester backbones with absorbable polymers such as poliglecaprone or polyglycolide, yielding implants engineered to balance initial tensile strength with controlled resorption kinetics. These hybrid constructs are prompting surgeons to reassess device selection based on tissue integration and the long-term foreign-body footprint.

Simultaneously, surgical approach trends are altering adoption patterns. The growth of laparoscopic and robotic-assisted procedures, together with refinements in open repair techniques, has amplified demand for meshes that are easy to handle, conformable, and compatible with various fixation strategies. The pursuit of shorter operating times and reduced postoperative pain is creating stronger alignment between device features and procedural workflows.

Concurrently, payer and hospital decision-makers are prioritizing evidence that demonstrates meaningful improvements in patient-centric outcomes, such as reduced chronic pain, fewer reoperations, and shorter recovery periods. This shift is encouraging manufacturers to deepen investments in clinical studies, registries, and post-market surveillance. Additionally, cost pressures and supply chain vulnerabilities are incentivizing partnerships and localized manufacturing strategies, which together are reshaping competitive dynamics and accelerating consolidation among suppliers that can deliver durable clinical evidence and reliable logistics.

How cumulative tariff shifts reshaped procurement priorities, supply chain resilience, regulatory compliance burdens, and commercial value propositions across the sector

United States tariff changes implemented in 2025 introduced a new set of considerations for manufacturers, distributors, and purchasers of partially absorbable hernia repair mesh. Tariff shifts increased the importance of upstream sourcing decisions and forced stakeholders to re-evaluate supplier footprints. For companies that relied on imported raw polymers, coating materials, or finished mesh devices, the immediate consequence was a reallocation of procurement strategy toward supply chain diversification and an intensified focus on nearshoring where feasible.

The cumulative impact of these trade measures has extended beyond unit cost pressure to influence inventory policies, contract negotiations, and commercial pricing strategies. Hospitals and ambulatory surgical centers, operating under strict cost-containment mandates, began prioritizing suppliers that could demonstrate stable lead times and transparent landed costs. As a result, some manufacturers accelerated investments in domestic manufacturing capacity or entered strategic partnerships with regional contract manufacturers to preserve margin and responsiveness.

Regulatory compliance and customs complexity also imposed higher administrative overhead, prompting firms to strengthen trade compliance capabilities and to explore alternative distribution channels such as direct sales models to better control pricing and service. Finally, the tariff environment amplified the value of differentiated clinical evidence and service bundles; providers showed greater willingness to pay for devices coupled with strong training, warranty, or outcome-guarantee programs that mitigated perceived financial risk in a higher-cost procurement landscape. The net effect was a reordering of competitive priorities where supply-chain resiliency, regulatory sophistication, and evidence-driven value propositions gained precedence.

Comprehensive segmentation narrative linking product formulations, clinical applications, surgical approaches, fixation strategies, end users, distribution models, and absorption-rate considerations

Understanding segmentation in partially absorbable hernia repair mesh is essential to translating clinical needs into product design and commercial strategy. When examining product type, combinations such as polyester with poliglecaprone and polyester with polyglycolide coexist alongside polypropylene paired with poliglecaprone and polypropylene paired with polyglycolide, each blend offering different handling, integration, and absorption profiles that appeal to distinct surgical preferences and tissue environments.

Application-driven segmentation highlights the range of clinical indications where these meshes are deployed. Femoral and inguinal repairs remain core use cases, while umbilical procedures require materials optimized for smaller defects and minimal contouring; ventral repairs, encompassing both incisional and primary ventral defects, present unique load-bearing demands and long-term tissue remodeling considerations that inform device architecture and fixation choices.

Surgical approach is another critical axis that shapes design and commercialization. Laparoscopic techniques, including totally extraperitoneal and transabdominal preperitoneal approaches, demand meshes that are easy to deploy through ports and conform to intraperitoneal anatomy. Open repairs, with techniques such as Lichtenstein and plug and patch, prioritize ease of fixation and pliability for tension-free placement. Robotic-assisted procedures, particularly robotic transabdominal preperitoneal techniques, create opportunities for meshes engineered for precision placement and minimal fixation.

Fixation method significantly influences device development and clinical adoption. Options such as glue, self-fixating designs, sutures, and tacks each carry distinct profiles in terms of procedure time, postoperative pain, and risk of recurrence, driving design trade-offs between adhesive surfaces, macrotexture, and edge reinforcement. End user segmentation matters for service and distribution strategies; ambulatory surgical centers, hospitals, and specialty clinics differ in purchasing cycles, inventory tolerance, and clinical pathways, which in turn affect how vendors position training, warranties, and pricing models.

Distribution channel and absorption-rate segmentation further refine go-to-market and product strategies. Direct sales, distributor sales, and e-commerce channels each impose different expectations for sales support, clinician training, and after-sales service. Meanwhile, absorption-rate differentiation-categorized as medium, rapid, and slow-enables targeted clinical messaging around healing timelines, foreign-body presence, and long-term tissue remodeling. When synthesized, these segmentation dimensions offer a framework for prioritizing product portfolios, clinical study design, and channel investment to meet the nuanced demands of surgeons, procurement leaders, and patients.

How regional clinical priorities, regulatory frameworks, and procurement behaviors in the Americas, Europe Middle East & Africa, and Asia-Pacific drive divergent adoption pathways and strategic responses

Regional dynamics shape competitive advantage, clinical adoption patterns, and regulatory navigation in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of leading surgical centers and a reimbursement environment that increasingly values long-term outcomes drive demand for devices supported by robust clinical evidence and surgeon training programs. Procurement cycles in this region emphasize contract performance, supply reliability, and demonstrable impact on patient-reported outcomes.

Across Europe, Middle East & Africa, regulatory heterogeneity and varying healthcare financing models create both challenges and opportunities. High-resource European markets prioritize safety, conformity to regulatory standards, and value-based procurement, while certain markets in the Middle East and Africa present growth opportunities tied to infrastructure expansion and rising surgical volumes. Navigating differing registration requirements and establishing local partnerships can accelerate entry and adoption.

In Asia-Pacific, a combination of rapid procedural volume growth, expanding surgical capacity, and government-driven healthcare investments fosters a dynamic demand environment. Cost sensitivity in some markets coexists with interest in advanced materials and minimally invasive approaches in major urban centers. Manufacturers that align product portfolios with regional clinical preferences and distribution models, while offering scalable training and support, are positioned to capture share of elective and complex hernia repair cases. Across all regions, localization of supply, regional regulatory expertise, and tailored clinical evidence strategies improve the speed and durability of commercial penetration.

How supplier strategies in materials innovation, clinical evidence investments, surgeon training, regulatory compliance, and service bundling are shaping competitive advantage

Competitive dynamics among leading firms supplying partially absorbable hernia repair mesh are characterized by sustained investment in materials science, expanding clinical evidence programs, and strategic partnerships that strengthen distribution and clinical training. Companies are differentiating through polymer blends that finely tune absorption rate and mechanical properties, proprietary manufacturing processes that ensure consistency and sterility, and surface engineering that enhances tissue ingrowth while reducing inflammatory response.

Beyond product innovation, firms are investing in surgeon education, simulation-based training, and center-of-excellence programs to accelerate adoption and generate real-world outcome data. Collaborations with key opinion leaders and surgical societies are increasingly important to establish clinical guidelines and to facilitate the generation of long-term safety and performance evidence. In regulatory arenas, companies are enhancing compliance infrastructures and post-market surveillance capabilities to meet heightened evidence expectations and to respond swiftly to adverse-event signals.

Commercial strategies are also evolving: organizations that combine robust clinical pipelines with compelling service offerings-such as procedure training, bundled care pathways, and outcome-linked contracting-are gaining traction with high-volume centers and integrated delivery networks. At the same time, smaller and niche players focus on highly differentiated materials or novel fixation mechanisms to carve out specialty indications. Overall, firms that balance R&D intensity with operational excellence, supply-chain resilience, and partnership-driven market access are best positioned to thrive in a more evidence-driven and cost-conscious landscape.

Practical strategic moves for leaders to accelerate adoption, strengthen supply chains, and convert clinical evidence into compelling value propositions for healthcare purchasers

Industry leaders seeking to translate insight into market leadership should align product development, regulatory strategy, and commercial execution around a few high-impact priorities. First, invest in modular product platforms that allow iterative tuning of absorption rate and mechanical properties so that clinical evidence can be built across multiple indications without requiring full redesign. This approach reduces time-to-clinic for adjacent applications and enables clearer differentiation by tailoring resorption kinetics to the tissue environment.

Second, prioritize multi-stakeholder evidence generation that combines randomized controlled trials with pragmatic registries and real-world data collection. Demonstrating improvements in patient-centered outcomes such as chronic pain reduction, return-to-function timelines, and lower reoperation rates is more persuasive to purchasers than device-only performance metrics. Engage surgeons early through training programs and outcome collaboratives to accelerate adoption and capture meaningful registry data.

Third, fortify supply chain resilience by diversifying supplier bases, pursuing regional manufacturing or contract-manufacturing partnerships, and investing in trade compliance capabilities. These steps mitigate tariff and logistics risks while enhancing responsiveness to high-volume customers. Fourth, tailor commercial models to end-user needs: hospitals and ambulatory surgical centers respond to different contracting approaches, so consider value-based bundles, performance guarantees, and integrated training services to de-risk adoption for purchasing committees.

Finally, integrate digital tools for surgeon engagement, product tracking, and post-market surveillance to enhance customer experience and regulatory readiness. Together, these steps create a defensible market position that balances innovation with operational reliability and evidence-backed value.

A rigorous mixed-methods methodology combining clinician interviews, regulatory and literature review, and expert validation to produce actionable, evidence-driven insights

The research approach underpinning this analysis combined qualitative and quantitative techniques to ensure depth, triangulation, and practical relevance. Primary qualitative inputs were collected through structured interviews with surgeons across minimally invasive and open hernia repair specialties, procurement leaders from hospitals and ambulatory surgical centers, and regulatory and reimbursement experts who advise on device pathways. These interviews provided first-hand perspectives on device handling preferences, fixation choices, and clinical evidence priorities.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and surgical society guidelines to map clinical practice patterns and safety considerations. Trade and policy analyses assessed recent tariff and trade developments and their operational implications. Data synthesis relied on cross-checking insights from diverse sources to identify convergent themes and to highlight areas of strategic differentiation.

To validate findings, an expert panel reviewed preliminary conclusions and provided feedback that informed final recommendations. Quality controls included source verification, methodological transparency, and sensitivity checks when interpreting evidence with limited long-term follow-up. The result is a corroborated set of insights designed to support clinical, commercial, and operational decision-makers without relying on single-source conclusions.

Synthesis of product innovation, evidence demands, and operational resilience as the foundation for durable adoption and improved patient outcomes in hernia repair

Partially absorbable hernia repair mesh represents a convergence of material science, surgical technique adaptation, and outcome-focused healthcare purchasing. Across product development, clinical adoption, and commercialization, the most successful organizations will be those that marry high-quality clinical evidence with resilient supply chains and tailored commercial models that address the unique needs of hospitals, ambulatory surgical centers, and specialty clinics. Strategic investments in polymer optimization, fixation innovation, and surgeon engagement programs will continue to drive differentiation.

Trade policy shifts and regional regulatory complexity have elevated the importance of localized manufacturing, robust trade compliance, and distribution agility. These operational enhancements, when coupled with rigorous post-market surveillance and multi-source clinical data, enable suppliers to sustain trust with clinicians and procurement groups. Ultimately, the path to durable adoption rests on demonstrating meaningful improvements in patient experiences and healthcare system efficiency, rather than on incremental product claims alone.

This synthesis underscores a core imperative for stakeholders across the value chain: prioritize evidence-generation, secure supply-chain continuity, and design commercial models that reduce adoption friction. Executed well, these priorities will accelerate clinician confidence and create pathways for safer, more reliable hernia repair solutions that meet the evolving expectations of patients and providers alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Partially Absorbable Hernia Repair Mesh Market, by Product Type

  • 8.1. Polyester And Poliglecaprone
  • 8.2. Polyester And Polyglycolide
  • 8.3. Polypropylene And Poliglecaprone
  • 8.4. Polypropylene And Polyglycolide

9. Partially Absorbable Hernia Repair Mesh Market, by Surgery Approach

  • 9.1. Laparoscopic
    • 9.1.1. Totally Extra Peritoneal
    • 9.1.2. Trans Abdominal Pre Peritoneal
  • 9.2. Open
    • 9.2.1. Lichtenstein
    • 9.2.2. Plug And Patch
  • 9.3. Robotic Assisted

10. Partially Absorbable Hernia Repair Mesh Market, by Fixation Method

  • 10.1. Glue
  • 10.2. Self Fixating
  • 10.3. Suture
  • 10.4. Tack

11. Partially Absorbable Hernia Repair Mesh Market, by Absorption Rate

  • 11.1. Medium
  • 11.2. Rapid
  • 11.3. Slow

12. Partially Absorbable Hernia Repair Mesh Market, by Application

  • 12.1. Femoral
  • 12.2. Inguinal
  • 12.3. Umbilical
  • 12.4. Ventral
    • 12.4.1. Incisional
    • 12.4.2. Primary Ventral

13. Partially Absorbable Hernia Repair Mesh Market, by End User

  • 13.1. Ambulatory Surgical Center
  • 13.2. Hospital
  • 13.3. Specialty Clinic

14. Partially Absorbable Hernia Repair Mesh Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Partially Absorbable Hernia Repair Mesh Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Partially Absorbable Hernia Repair Mesh Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Partially Absorbable Hernia Repair Mesh Market

18. China Partially Absorbable Hernia Repair Mesh Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AbbVie Inc.
  • 19.6. Aran Biomedical by Integer Holdings Corporation
  • 19.7. B. Braun SE
  • 19.8. Baxter International Inc.
  • 19.9. Becton, Dickinson and Company
  • 19.10. Betatech Medical
  • 19.11. BioCer Entwicklungs-GmbH
  • 19.12. Boston Scientific Corporation
  • 19.13. Coloplast A/S
  • 19.14. CooperSurgical, Inc.
  • 19.15. Cousin Surgery
  • 19.16. Deep Blue Medical Advances, Inc.
  • 19.17. Dolphin Sutures
  • 19.18. Getinge AB
  • 19.19. HERNIAMESH S.r.l.
  • 19.20. Hwainmedi Co., Ltd.
  • 19.21. Insightra Medical Inc.
  • 19.22. Integra LifeSciences Holdings Corporation
  • 19.23. Intuitive Surgical, Inc.
  • 19.24. Johnson & Johnson Services, Inc.
  • 19.25. KATSAN Katgut Sanayi ve Tic. A.S.
  • 19.26. Medtronic PLC
  • 19.27. Meril Life Sciences Pvt. Ltd.
  • 19.28. Momentis Surgical Ltd.
  • 19.29. Novus Scientific AB
  • 19.30. Olympus Corporation
  • 19.31. Secant Group, LLC
  • 19.32. Surgimatix, Inc.
  • 19.33. TELA Bio, Inc.
  • 19.34. W. L. Gore & Associates, Inc.
  • 19.35. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYESTER AND POLIGLECAPRONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYESTER AND POLIGLECAPRONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYESTER AND POLIGLECAPRONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYESTER AND POLYGLYCOLIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYESTER AND POLYGLYCOLIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYESTER AND POLYGLYCOLIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYPROPYLENE AND POLIGLECAPRONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYPROPYLENE AND POLIGLECAPRONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYPROPYLENE AND POLIGLECAPRONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYPROPYLENE AND POLYGLYCOLIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYPROPYLENE AND POLYGLYCOLIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY POLYPROPYLENE AND POLYGLYCOLIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TOTALLY EXTRA PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TOTALLY EXTRA PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TOTALLY EXTRA PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TRANS ABDOMINAL PRE PERITONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TRANS ABDOMINAL PRE PERITONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TRANS ABDOMINAL PRE PERITONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LICHTENSTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LICHTENSTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LICHTENSTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PLUG AND PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PLUG AND PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PLUG AND PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY GLUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY GLUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY GLUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SELF FIXATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SELF FIXATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SELF FIXATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SUTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SUTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SUTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY TACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY MEDIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY MEDIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY RAPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY RAPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY RAPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY INGUINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY INGUINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY INGUINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRIMARY VENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRIMARY VENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRIMARY VENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 217. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 218. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 219. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 220. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 223. G7 PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 227. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 228. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 229. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 230. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 233. NATO PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY SURGERY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY OPEN, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY ABSORPTION RATE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY VENTRAL, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA PARTIALLY ABSORBABLE HERNIA REPAIR MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)